Search research articles
Contact Us
Filters
Showing results (41-50 of 97) with videos related to
Page
of 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 13, 2022
Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Virus Infections in Lung Transplant Recipients: A Systematic Review of Outcomes and Treatment Strategies
Auke de Zwart, Annelies Riezebos-Brilman, Gerton Lunter, et al.
Antimicrobial Agents and Chemotherapy
|
April 25, 2023
Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens
Yue Zhu, Limei Zhu, Lina Davies Forsman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 15, 2026
Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management
Katarina Niward, Clara Braian, Gustav Svärdhagen, et al.
International Journal of Antimicrobial Agents
|
September 19, 2023
Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen
Sanjay Singh, Tawanda Gumbo, Jan-Willem Alffenaar, et al.
Biomedicines
|
October 23, 2021
Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs?
Ana Rita da Silva Ferreira, Anne-Grete Märtson, Alyse de Boer, et al.
Clinical Pharmacokinetics
|
July 3, 2025
Rifampicin Exposure in Tuberculosis Patients with Comorbidities in Sub-Saharan Africa: Prioritising Populations for Treatment-A Systematic Review and Meta-analysis
Bibie Said, Yuan Pétermann, Patrick Howlett, et al.
The Journal of Antimicrobial Chemotherapy
|
April 6, 2024
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations
Ralf Stemkens, Chaima Mouhdad, Eric J F Franssen, et al.
JMIR Mhealth and Uhealth
|
November 2, 2020
Patients and Medical Staff Attitudes Toward the Future Inclusion of eHealth in Tuberculosis Management: Perspectives From Six Countries Evaluated using a Qualitative Framework
Ioana Margineanu, Christina Louka, Maria Vincenti-Gonzalez, et al.
Tropical Medicine & International Health : TM & IH
|
May 25, 2024
Tuberculosis impacts multiple aspects in quality of life in a Romanian cohort of drug-susceptible and drug resistant patients: A patient-reported outcome measures study
Ioana Margineanu, Teodora Butnaru, Marjolein Lam, et al.
Journal of Medical Internet Research
|
February 23, 2022
Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials
Abdurahman Ridho, Sofa D Alfian, Job F M van Boven, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 97) with videos related to
Sort By:
Page
of 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 13, 2022
Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Virus Infections in Lung Transplant Recipients: A Systematic Review of Outcomes and Treatment Strategies
Auke de Zwart, Annelies Riezebos-Brilman, Gerton Lunter, et al.
Antimicrobial Agents and Chemotherapy
|
April 25, 2023
Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens
Yue Zhu, Limei Zhu, Lina Davies Forsman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 15, 2026
Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management
Katarina Niward, Clara Braian, Gustav Svärdhagen, et al.
International Journal of Antimicrobial Agents
|
September 19, 2023
Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen
Sanjay Singh, Tawanda Gumbo, Jan-Willem Alffenaar, et al.
Biomedicines
|
October 23, 2021
Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs?
Ana Rita da Silva Ferreira, Anne-Grete Märtson, Alyse de Boer, et al.
Clinical Pharmacokinetics
|
July 3, 2025
Rifampicin Exposure in Tuberculosis Patients with Comorbidities in Sub-Saharan Africa: Prioritising Populations for Treatment-A Systematic Review and Meta-analysis
Bibie Said, Yuan Pétermann, Patrick Howlett, et al.
The Journal of Antimicrobial Chemotherapy
|
April 6, 2024
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations
Ralf Stemkens, Chaima Mouhdad, Eric J F Franssen, et al.
JMIR Mhealth and Uhealth
|
November 2, 2020
Patients and Medical Staff Attitudes Toward the Future Inclusion of eHealth in Tuberculosis Management: Perspectives From Six Countries Evaluated using a Qualitative Framework
Ioana Margineanu, Christina Louka, Maria Vincenti-Gonzalez, et al.
Tropical Medicine & International Health : TM & IH
|
May 25, 2024
Tuberculosis impacts multiple aspects in quality of life in a Romanian cohort of drug-susceptible and drug resistant patients: A patient-reported outcome measures study
Ioana Margineanu, Teodora Butnaru, Marjolein Lam, et al.
Journal of Medical Internet Research
|
February 23, 2022
Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials
Abdurahman Ridho, Sofa D Alfian, Job F M van Boven, et al.
Page
of 10